Protein S100A8/A9: A Potential New Biomarker for Pancreatic Diseases
Open Access
- 19 September 2017
- journal article
- Published by Peertechz Publications Private Limited in International Journal of Clinical Endocrinology and Metabolism
- Vol. 3 (1), 023-028
- https://doi.org/10.17352/ijcem.000025
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- S100A8 and S100A9 Are Associated with Colorectal Carcinoma Progression and Contribute to Colorectal Carcinoma Cell Survival and Migration via Wnt/β-Catenin PathwayPLOS ONE, 2013
- Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N-terminal peptide (NT-S100A8)Journal of Cellular Physiology, 2010
- Inflammation-associated S100 proteins: new mechanisms that regulate functionAmino Acids, 2010
- Proteomic Analyses of Pancreatic Cyst FluidsPancreas, 2009
- Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 proteinThe Journal of Experimental Medicine, 2008
- Calcium-dependent and -independent interactions of the S100 protein familyBiochemical Journal, 2006
- Calcium-Binding Proteins S100A8 and S100A9 as Novel Diagnostic Markers in Human Prostate CancerClinical Cancer Research, 2005
- A Phenylarsine Oxide-Binding Protein of Neutrophil Cytosol, Which Belongs to the S100 Family, Potentiates NADPH Oxidase ActivationBiochemical and Biophysical Research Communications, 2001
- The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: The S100A9 and S100A8 positive cells underlie and invade tumor massElectrophoresis, 1999
- A soluble protein characteristic of the nervous systemBiochemical and Biophysical Research Communications, 1965